Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Prostate Fusion Biopsy Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Prostate Fusion Biopsy Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-07-31
Pages: 144 Pages
Report ld: 4812780
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Prostate Fusion Biopsy Market Size(US$)
CAGR 2025-2031
5.5%
Market Size,2031
USD 756
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 549 million
Market Forecast in 2031(Value)
US$ 756 million
CAGR
5.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Prostate Fusion Biopsy market is projected to grow from US$ 523 million in 2024 to US$ 756 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A Prostate Fusion Biopsy is a medical procedure used to obtain tissue samples from the prostate gland to diagnose prostate cancer. It combines two imaging techniques—transrectal ultrasound (TRUS) and magnetic resonance imaging (MRI)—to guide the biopsy. This fusion of imaging helps doctors precisely target areas of the prostate that may be suspicious for cancer, especially in cases where previous biopsies were inconclusive or in patients with elevated prostate-specific antigen (PSA) levels but no obvious abnormalities on ultrasound.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Prostate Fusion Biopsy leading manufacturers including Philips, GE Healthcare, KOELIS, FUJIFILM, Eigen Health, Canon, Esaote SPA, Shenzhen Mindray Bio-Medical Electronics, etc., dominate supply; the top five capture approximately % of global revenue, with Philips leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Prostate Fusion Biopsy market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Philips
- GE Healthcare
- KOELIS
- FUJIFILM
- Eigen Health
- Canon
- Esaote SPA
- Shenzhen Mindray Bio-Medical Electronics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Equipment
- Consumables
Segment by Application
- Hospital
- Laboratory
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Prostate Fusion Biopsy study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Prostate Fusion Biopsy: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Prostate Fusion Biopsy Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Equipment
1.2.3 Consumables
1.3 Market Segmentation by Application
1.3.1 Global Prostate Fusion Biopsy Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Prostate Fusion Biopsy Revenue Estimates and Forecasts 2020-2031
2.2 Global Prostate Fusion Biopsy Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Prostate Fusion Biopsy Sales Estimates and Forecasts 2020-2031
2.4 Global Prostate Fusion Biopsy Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Prostate Fusion Biopsy Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Prostate Fusion Biopsy Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Equipment Market Size by Manufacturers
3.5.2 Consumables Market Size by Manufacturers
3.6 Global Prostate Fusion Biopsy Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Prostate Fusion Biopsy Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Prostate Fusion Biopsy Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Prostate Fusion Biopsy Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Prostate Fusion Biopsy Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Prostate Fusion Biopsy Sales and Revenue by Type (2020-2031)
6.4 North America Prostate Fusion Biopsy Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Prostate Fusion Biopsy Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Prostate Fusion Biopsy Sales and Revenue by Type (2020-2031)
7.4 Europe Prostate Fusion Biopsy Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Prostate Fusion Biopsy Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Prostate Fusion Biopsy Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Prostate Fusion Biopsy Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Prostate Fusion Biopsy Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Prostate Fusion Biopsy Sales and Revenue by Type (2020-2031)
9.4 Central and South America Prostate Fusion Biopsy Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Prostate Fusion Biopsy Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Prostate Fusion Biopsy Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Prostate Fusion Biopsy Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Prostate Fusion Biopsy Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Philips
11.1.1 Philips Corporation Information
11.1.2 Philips Business Overview
11.1.3 Philips Prostate Fusion Biopsy Product Models, Descriptions and Specifications
11.1.4 Philips Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Philips Prostate Fusion Biopsy Sales by Product in 2024
11.1.6 Philips Prostate Fusion Biopsy Sales by Application in 2024
11.1.7 Philips Prostate Fusion Biopsy Sales by Geographic Area in 2024
11.1.8 Philips Prostate Fusion Biopsy SWOT Analysis
11.1.9 Philips Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Corporation Information
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Prostate Fusion Biopsy Product Models, Descriptions and Specifications
11.2.4 GE Healthcare Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 GE Healthcare Prostate Fusion Biopsy Sales by Product in 2024
11.2.6 GE Healthcare Prostate Fusion Biopsy Sales by Application in 2024
11.2.7 GE Healthcare Prostate Fusion Biopsy Sales by Geographic Area in 2024
11.2.8 GE Healthcare Prostate Fusion Biopsy SWOT Analysis
11.2.9 GE Healthcare Recent Developments
11.3 KOELIS
11.3.1 KOELIS Corporation Information
11.3.2 KOELIS Business Overview
11.3.3 KOELIS Prostate Fusion Biopsy Product Models, Descriptions and Specifications
11.3.4 KOELIS Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 KOELIS Prostate Fusion Biopsy Sales by Product in 2024
11.3.6 KOELIS Prostate Fusion Biopsy Sales by Application in 2024
11.3.7 KOELIS Prostate Fusion Biopsy Sales by Geographic Area in 2024
11.3.8 KOELIS Prostate Fusion Biopsy SWOT Analysis
11.3.9 KOELIS Recent Developments
11.4 FUJIFILM
11.4.1 FUJIFILM Corporation Information
11.4.2 FUJIFILM Business Overview
11.4.3 FUJIFILM Prostate Fusion Biopsy Product Models, Descriptions and Specifications
11.4.4 FUJIFILM Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 FUJIFILM Prostate Fusion Biopsy Sales by Product in 2024
11.4.6 FUJIFILM Prostate Fusion Biopsy Sales by Application in 2024
11.4.7 FUJIFILM Prostate Fusion Biopsy Sales by Geographic Area in 2024
11.4.8 FUJIFILM Prostate Fusion Biopsy SWOT Analysis
11.4.9 FUJIFILM Recent Developments
11.5 Eigen Health
11.5.1 Eigen Health Corporation Information
11.5.2 Eigen Health Business Overview
11.5.3 Eigen Health Prostate Fusion Biopsy Product Models, Descriptions and Specifications
11.5.4 Eigen Health Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Eigen Health Prostate Fusion Biopsy Sales by Product in 2024
11.5.6 Eigen Health Prostate Fusion Biopsy Sales by Application in 2024
11.5.7 Eigen Health Prostate Fusion Biopsy Sales by Geographic Area in 2024
11.5.8 Eigen Health Prostate Fusion Biopsy SWOT Analysis
11.5.9 Eigen Health Recent Developments
11.6 Canon
11.6.1 Canon Corporation Information
11.6.2 Canon Business Overview
11.6.3 Canon Prostate Fusion Biopsy Product Models, Descriptions and Specifications
11.6.4 Canon Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Canon Recent Developments
11.7 Esaote SPA
11.7.1 Esaote SPA Corporation Information
11.7.2 Esaote SPA Business Overview
11.7.3 Esaote SPA Prostate Fusion Biopsy Product Models, Descriptions and Specifications
11.7.4 Esaote SPA Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Esaote SPA Recent Developments
11.8 Shenzhen Mindray Bio-Medical Electronics
11.8.1 Shenzhen Mindray Bio-Medical Electronics Corporation Information
11.8.2 Shenzhen Mindray Bio-Medical Electronics Business Overview
11.8.3 Shenzhen Mindray Bio-Medical Electronics Prostate Fusion Biopsy Product Models, Descriptions and Specifications
11.8.4 Shenzhen Mindray Bio-Medical Electronics Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Shenzhen Mindray Bio-Medical Electronics Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Prostate Fusion Biopsy Industry Chain
12.2 Prostate Fusion Biopsy Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Prostate Fusion Biopsy Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Prostate Fusion Biopsy Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Prostate Fusion Biopsy Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Prostate Fusion Biopsy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Prostate Fusion Biopsy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Prostate Fusion Biopsy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Prostate Fusion Biopsy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Prostate Fusion Biopsy Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Prostate Fusion Biopsy Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Prostate Fusion Biopsy Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
Table 7. Global Prostate Fusion Biopsy Sales by Region (2020-2025) & (Units)
Table 8. Global Prostate Fusion Biopsy Sales by Region (2026-2031) & (Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Prostate Fusion Biopsy Sales by Manufacturers (2020-2025) & (Units)
Table 11. Global Prostate Fusion Biopsy Sales Share by Manufacturers (2020-2025)
Table 12. Global Prostate Fusion Biopsy Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Prostate Fusion Biopsy Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Prostate Fusion Biopsy by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Fusion Biopsy as of 2024)
Table 16. Global Prostate Fusion Biopsy Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Prostate Fusion Biopsy Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Prostate Fusion Biopsy Manufacturing Base and Headquarters
Table 19. Global Prostate Fusion Biopsy Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Prostate Fusion Biopsy Sales by Type (2020-2025) & (Units)
Table 23. Global Prostate Fusion Biopsy Sales by Type (2026-2031) & (Units)
Table 24. Global Prostate Fusion Biopsy Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Prostate Fusion Biopsy Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Prostate Fusion Biopsy ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Prostate Fusion Biopsy Sales by Application (2020-2025) & (Units)
Table 29. Global Prostate Fusion Biopsy Sales by Application (2026-2031) & (Units)
Table 30. Prostate Fusion Biopsy High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Prostate Fusion Biopsy Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Prostate Fusion Biopsy Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Prostate Fusion Biopsy ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Prostate Fusion Biopsy Growth Accelerators and Market Barriers
Table 37. North America Prostate Fusion Biopsy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Prostate Fusion Biopsy Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Prostate Fusion Biopsy Growth Accelerators and Market Barriers
Table 40. Europe Prostate Fusion Biopsy Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Prostate Fusion Biopsy Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Prostate Fusion Biopsy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Prostate Fusion Biopsy Sales (Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Prostate Fusion Biopsy Growth Accelerators and Market Barriers
Table 45. Southeast Asia Prostate Fusion Biopsy Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Prostate Fusion Biopsy Investment Opportunities and Key Challenges
Table 47. Central and South America Prostate Fusion Biopsy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Prostate Fusion Biopsy Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Prostate Fusion Biopsy Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Philips Corporation Information
Table 51. Philips Description and Major Businesses
Table 52. Philips Product Models, Descriptions and Specifications
Table 53. Philips Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Philips Sales Value Proportion by Product in 2024
Table 55. Philips Sales Value Proportion by Application in 2024
Table 56. Philips Sales Value Proportion by Geographic Area in 2024
Table 57. Philips Prostate Fusion Biopsy SWOT Analysis
Table 58. Philips Recent Developments
Table 59. GE Healthcare Corporation Information
Table 60. GE Healthcare Description and Major Businesses
Table 61. GE Healthcare Product Models, Descriptions and Specifications
Table 62. GE Healthcare Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. GE Healthcare Sales Value Proportion by Product in 2024
Table 64. GE Healthcare Sales Value Proportion by Application in 2024
Table 65. GE Healthcare Sales Value Proportion by Geographic Area in 2024
Table 66. GE Healthcare Prostate Fusion Biopsy SWOT Analysis
Table 67. GE Healthcare Recent Developments
Table 68. KOELIS Corporation Information
Table 69. KOELIS Description and Major Businesses
Table 70. KOELIS Product Models, Descriptions and Specifications
Table 71. KOELIS Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. KOELIS Sales Value Proportion by Product in 2024
Table 73. KOELIS Sales Value Proportion by Application in 2024
Table 74. KOELIS Sales Value Proportion by Geographic Area in 2024
Table 75. KOELIS Prostate Fusion Biopsy SWOT Analysis
Table 76. KOELIS Recent Developments
Table 77. FUJIFILM Corporation Information
Table 78. FUJIFILM Description and Major Businesses
Table 79. FUJIFILM Product Models, Descriptions and Specifications
Table 80. FUJIFILM Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. FUJIFILM Sales Value Proportion by Product in 2024
Table 82. FUJIFILM Sales Value Proportion by Application in 2024
Table 83. FUJIFILM Sales Value Proportion by Geographic Area in 2024
Table 84. FUJIFILM Prostate Fusion Biopsy SWOT Analysis
Table 85. FUJIFILM Recent Developments
Table 86. Eigen Health Corporation Information
Table 87. Eigen Health Description and Major Businesses
Table 88. Eigen Health Product Models, Descriptions and Specifications
Table 89. Eigen Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Eigen Health Sales Value Proportion by Product in 2024
Table 91. Eigen Health Sales Value Proportion by Application in 2024
Table 92. Eigen Health Sales Value Proportion by Geographic Area in 2024
Table 93. Eigen Health Prostate Fusion Biopsy SWOT Analysis
Table 94. Eigen Health Recent Developments
Table 95. Canon Corporation Information
Table 96. Canon Description and Major Businesses
Table 97. Canon Product Models, Descriptions and Specifications
Table 98. Canon Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Canon Recent Developments
Table 100. Esaote SPA Corporation Information
Table 101. Esaote SPA Description and Major Businesses
Table 102. Esaote SPA Product Models, Descriptions and Specifications
Table 103. Esaote SPA Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Esaote SPA Recent Developments
Table 105. Shenzhen Mindray Bio-Medical Electronics Corporation Information
Table 106. Shenzhen Mindray Bio-Medical Electronics Description and Major Businesses
Table 107. Shenzhen Mindray Bio-Medical Electronics Product Models, Descriptions and Specifications
Table 108. Shenzhen Mindray Bio-Medical Electronics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Shenzhen Mindray Bio-Medical Electronics Recent Developments
Table 110. Key Raw Materials Distribution
Table 111. Raw Materials Key Suppliers
Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 113. Milestones in Production Technology Evolution
Table 114. Distributors List
Table 115. Market Trends and Market Evolution
Table 116. Market Drivers and Opportunities
Table 117. Market Challenges, Risks, and Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Prostate Fusion Biopsy Product Picture
Figure 2. Global Prostate Fusion Biopsy Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Equipment Product Picture
Figure 4. Consumables Product Picture
Figure 5. Global Prostate Fusion Biopsy Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital
Figure 7. Laboratory
Figure 8. Others
Figure 9. Prostate Fusion Biopsy Report Years Considered
Figure 10. Global Prostate Fusion Biopsy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 12. Global Prostate Fusion Biopsy Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Prostate Fusion Biopsy Revenue Market Share by Region (2020-2031)
Figure 14. Global Prostate Fusion Biopsy Sales (2020-2031) & (Units)
Figure 15. Global Prostate Fusion Biopsy Sales (CAGR) by Region (2020-2031) (Units)
Figure 16. Global Prostate Fusion Biopsy Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Prostate Fusion Biopsy Sales Volume Market Share in 2024
Figure 18. Global Prostate Fusion Biopsy Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Equipment Revenue Market Share by Manufacturer in 2024
Figure 21. Consumables Revenue Market Share by Manufacturer in 2024
Figure 22. Global Prostate Fusion Biopsy Sales Market Share by Type (2020-2031)
Figure 23. Global Prostate Fusion Biopsy Revenue Market Share by Type (2020-2031)
Figure 24. Global Prostate Fusion Biopsy Sales Market Share by Application (2020-2031)
Figure 25. Global Prostate Fusion Biopsy Revenue Market Share by Application (2020-2031)
Figure 26. North America Prostate Fusion Biopsy Sales YoY (2020-2031) & (Units)
Figure 27. North America Prostate Fusion Biopsy Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Prostate Fusion Biopsy Sales Revenue (US$ Million) in 2024
Figure 29. North America Prostate Fusion Biopsy Sales Volume (Units) by Type (2020- 2031)
Figure 30. North America Prostate Fusion Biopsy Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Prostate Fusion Biopsy Sales Volume (Units) by Application (2020-2031)
Figure 32. North America Prostate Fusion Biopsy Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Prostate Fusion Biopsy Sales YoY (2020-2031) & (Units)
Figure 37. Europe Prostate Fusion Biopsy Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Prostate Fusion Biopsy Sales Revenue (US$ Million) in 2024
Figure 39. Europe Prostate Fusion Biopsy Sales Volume (Units) by Type (2020-2031)
Figure 40. Europe Prostate Fusion Biopsy Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Prostate Fusion Biopsy Sales Volume (Units) by Application (2020-2031)
Figure 42. Europe Prostate Fusion Biopsy Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 44. France Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Prostate Fusion Biopsy Sales YoY (2020-2031) & (Units)
Figure 49. Asia-Pacific Prostate Fusion Biopsy Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Prostate Fusion Biopsy Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Prostate Fusion Biopsy Sales Volume (Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Prostate Fusion Biopsy Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Prostate Fusion Biopsy Sales Volume (Units) by Application (2020-2031)
Figure 54. Asia-Pacific Prostate Fusion Biopsy Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 59. India Prostate Fusion Biopsy Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Prostate Fusion Biopsy Sales YoY (2020-2031) & (Units)
Figure 61. Central and South America Prostate Fusion Biopsy Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Prostate Fusion Biopsy Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Prostate Fusion Biopsy Sales Volume (Units) by Type (2021-2031)
Figure 64. Central and South America Prostate Fusion Biopsy Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Prostate Fusion Biopsy Sales Volume (Units) by Application (2020-2031)
Figure 66. Central and South America Prostate Fusion Biopsy Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Prostate Fusion Biopsy Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Prostate Fusion Biopsy Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Prostate Fusion Biopsy Sales YoY (2020-2031) & (Units)
Figure 70. Middle East and Africa Prostate Fusion Biopsy Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Prostate Fusion Biopsy Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Prostate Fusion Biopsy Sales Volume (Units) by Type (2021-2031)
Figure 73. South America Prostate Fusion Biopsy Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Prostate Fusion Biopsy Sales Volume (Units) by Application (2020-2031)
Figure 75. Middle East and Africa Prostate Fusion Biopsy Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Prostate Fusion Biopsy Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Prostate Fusion Biopsy Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Prostate Fusion Biopsy Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Prostate Fusion Biopsy Revenue (2020-2025) & (US$ Million)
Figure 80. Prostate Fusion Biopsy Industry Chain Mapping
Figure 81. Regional Prostate Fusion Biopsy Manufacturing Base Distribution (%)
Figure 82. Global Prostate Fusion Biopsy Production Market Share by Region (2020-2031)
Figure 83. Prostate Fusion Biopsy Production Process
Figure 84. Regional Prostate Fusion Biopsy Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Prostate Fusion Biopsy market?
The top companies in the global Prostate Fusion Biopsy market are Philips、GE Healthcare、KOELIS.
What was the global market size of Prostate Fusion Biopsy in 2031?
What is the annual compound growth rate of the global Prostate Fusion Biopsy market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Prostate Fusion Biopsy in 2025?
Related Reports
Global Prostate Fusion Biopsy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Prostate Fusion Biopsy market is projected to grow from US$ 549 million in 2025 to US$ 794 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 136
USD 4900.00
(Single User License)
Global Prostate Fusion Biopsy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Prostate Fusion Biopsy market size was US$ 549 million in 2025 and is forecast to reach a readjusted size of US$ 794 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 76
USD 4250.00
(Single User License)
Prostate Fusion Biopsy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 549 million in 2025 and is projected to reach US$ 794 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 102
USD 3950.00
(Single User License)
Global Prostate Fusion Biopsy Market Research Report 2026
The global Prostate Fusion Biopsy market was valued at US$ 549 million in 2025 and is anticipated to reach US$ 794 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 116
USD 2900.00
(Single User License)
Global Prostate Fusion Biopsy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Prostate Fusion Biopsy market size was US$ 523 million in 2024 and is forecast to a readjusted size of US$ 756 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 78
USD 4250.00
(Single User License)
Prostate Fusion Biopsy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 523 million in 2024 and is forecast to a readjusted size of US$ 756 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 99
USD 3950.00
(Single User License)
Global Prostate Fusion Biopsy Market Research Report 2025
The global market for Prostate Fusion Biopsy was valued at US$ 523 million in the year 2024 and is projected to reach a revised size of US$ 756 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2025-03-10
Pages: 85
USD 2900.00
(Single User License)
Prostate Fusion Biopsy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 461 million in 2023 and is forecast to a readjusted size of US$ 721 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030.
Published Date: 2024-12-12
Pages: 94
USD 3950.00
(Single User License)
Global Prostate Fusion Biopsy Market Research Report 2024
The global market for Prostate Fusion Biopsy was valued at US$ 461 million in the year 2023 and is projected to reach a revised size of US$ 721 million by 2030, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2024-12-12
Pages: 81
USD 2900.00
(Single User License)
Global Prostate Fusion Biopsy Market Insights, Forecast to 2030
Valued at US$ 523 million in 2024, the global Prostate Fusion Biopsy market is forecast to reach US$ 721 million by 2030, at a CAGR of 5.5% during the forecast period.
Published Date: 2024-12-12
Pages: 131
USD 4900.00
(Single User License)
Global Prostate Fusion Biopsy Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Prostate Fusion Biopsy market is projected to grow from US$ 549 million in 2025 to US$ 794 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 136
USD 4900.00 (Single User License)Global Prostate Fusion Biopsy Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Prostate Fusion Biopsy market size was US$ 549 million in 2025 and is forecast to reach a readjusted size of US$ 794 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 76
USD 4250.00 (Single User License)Prostate Fusion Biopsy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 549 million in 2025 and is projected to reach US$ 794 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-19
Pages: 102
USD 3950.00 (Single User License)Global Prostate Fusion Biopsy Market Research Report 2026
The global Prostate Fusion Biopsy market was valued at US$ 549 million in 2025 and is anticipated to reach US$ 794 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 116
USD 2900.00 (Single User License)Global Prostate Fusion Biopsy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Prostate Fusion Biopsy market size was US$ 523 million in 2024 and is forecast to a readjusted size of US$ 756 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 78
USD 4250.00 (Single User License)Prostate Fusion Biopsy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 523 million in 2024 and is forecast to a readjusted size of US$ 756 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 99
USD 3950.00 (Single User License)Global Prostate Fusion Biopsy Market Research Report 2025
The global market for Prostate Fusion Biopsy was valued at US$ 523 million in the year 2024 and is projected to reach a revised size of US$ 756 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-03-10
Pages: 85
USD 2900.00 (Single User License)Prostate Fusion Biopsy- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 461 million in 2023 and is forecast to a readjusted size of US$ 721 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030.
Published: 2024-12-12
Pages: 94
USD 3950.00 (Single User License)Global Prostate Fusion Biopsy Market Research Report 2024
The global market for Prostate Fusion Biopsy was valued at US$ 461 million in the year 2023 and is projected to reach a revised size of US$ 721 million by 2030, growing at a CAGR of 5.5% during the forecast period.
Published: 2024-12-12
Pages: 81
USD 2900.00 (Single User License)Global Prostate Fusion Biopsy Market Insights, Forecast to 2030
Valued at US$ 523 million in 2024, the global Prostate Fusion Biopsy market is forecast to reach US$ 721 million by 2030, at a CAGR of 5.5% during the forecast period.
Published: 2024-12-12
Pages: 131
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now